Drug-Induced Pulmonary Arterial Hypertension: A More Complicated Prognosis
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
All articles by Suzanne Bujara
Is It Time for Endocrinologists to Join the Vascular Care Team?
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.
Pulmonary Hypertension Screening Adaptations for Adult Congenital Heart Disease
Because standardized approaches for echocardiographic screening are impractical for certain subgroups of people with congenital heart disease, experts offered screening adaptations for pulmonary hypertension.
Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look
Despite the frequency with which it occurs, familial hypercholesterolemia often goes undiagnosed, with only 10% of affected patients aware of this genetic disorder.
Bipolar Disorder and the Cardiovascular System
Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.
PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes
Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.
Nutraceuticals May Benefit Patients Who Are Statin Intolerant
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
Unraveling the Relationship Between COPD and Stroke
Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.
Connective Tissue Diseases in Comorbid PAH: A Case for Separating SSc, SLE
Recent evidence suggests that systemic sclerosis and systemic lupus erythematosus comorbid with pulmonary arterial hypertension should be considered separate diseases.
Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
Despite public perception that cannabis is “natural” and “safe,” it has been implicated in many serious cardiovascular events, even in young, otherwise healthy people.
Next post in Hypertension
